Roundtable on impacts of GDPR on EU-US science collaborationThis session will consider how emerging regulations in data protection, medical devices and in-vitro diagnostics influence cooperation between Africa and the European Union.
The session will focus on the European General Data Protection regulation and its influence on the Global stage. Given that its scope already extends beyond the borders of the European Union, it is arguably becoming the template for global legislation.
Therefore, the session is designed to impart up-to-date information on the European Union's GDPR; to look specifically at related research collaboration between South Africa and African and the European Union and the impact of the GDPR on those research activities, in particular in the area of health. The meeting will also raise awareness of the emergence globally of data protection regulations and related future developments in South Africa and more generally in the continent of Africa.
The GDPR also addresses the transfer of personal data outside the EU, including to African nations. The GDPR aims to give control to individuals over their personal data, to ensure the free flow of personal data between Member States and to simplify the regulatory environment for international business by unifying the regulation within the EU.
Because research involving human health, drug safety and clinical trials requires the processing of personal data, the GDPR has posed particular challenges to the research sector both within the EU and elsewhere.
As the “Africa Initiative” is an integral part of the first Work Programme for 2021-2022 of the recently adopted “Horizon Europe”, it is important to consider how African Nations address should compliance and prepare for future data protection regulations in Africa.
The meeting will bring together policy and research leadership from the EU and US. One relevant issue on the agenda will be the EU's data protection regulation, the GDPR. The objective will be to create a much-needed forum for discussion on the broader implications of this regulation on transatlantic science cooperation, at a time when the regulation is arguably becoming a template for similar legislation globally.
15h00 Declan Kirrane, Chairman, ISC, Belgium15h05 Manuel Heitor, Science Minister, Portugal and chair of the Competitiveness Council during the Portuguese Council Presidency
15h15 Eva Kaili MEP Member of the European Parliament, Belgium
15h25 Didier Reynders European Commissioner for Justice, Belgium
15h30 Lydia Kline, National Institutes of Health, United States
15h40 Kurt Zatloukal Kurt Zatloukal Medical University Graz, Austria
15h50 Thomas Lyons, The American Society for Microbiology (ASM), United States
16h00 Rita Lawlor, University of Verona, Italy
16h10 Robin Frears, Federation of European Academies of Medicine, Brussels
16h20 Dario Gil, IBM Research, United States
16h30 David Brey, Atlantic Council, United States
16h40 Susan Veldsman, Academy of Science South Africa
16h45 Rahma Rachdi, Europe Correspondent, United States Press Agency
16h45 Discussion
17h00 Conclusion
ALLEA-EASAC-FEAM published a recent report:
https://easac.eu/fileadmin/PDF_s/reports_statements/Health_Data/International_Health_Data_Transfer_2021_web.pdf